Key indicators: single-crystal X-ray study; T = 294 K; mean (C-C) = 0.002 Å; R factor = 0.046; wR factor = 0.138; data-to-parameter ratio = 25.0.
In the molecule of the title compound, C 19 H 17 ClN 2 O, the heterocyclic six-membered ring adopts a half-chair conformation, while the pyrrolidine ring has an envelope conformation. In the crystal structure, C-ClÁ Á Á [ClÁ Á Ácentroid = 3.680 (2) Å ] interactions and van der Waals forces are present.
Related literature
For general background, see: Caine (1993) ; Tidey (1992) ; Carlson (1993); Sokoloff et al. (1990) ; Wilner (1985) ; Biava et al. (2005) ; Fernandes et al. (2004) ; Borthwick et al. (2000) ; Jiang et al. (2004) . For bond-length data, see: Allen et al. (1987) . For puckering parameters, see: Cremer & Pople (1975) . For asymmetry parameters, see: Nardelli (1995) . 
Data collection
Bruker Kappa APEX2 diffractometer Absorption correction: multi-scan (Blessing, 1995) T min = 0.935, T max = 0.953 21338 measured reflections 5199 independent reflections 3858 reflections with I > 2(I) R int = 0.020 Refinement R[F 2 > 2(F 2 )] = 0.046 wR(F 2 ) = 0.138 S = 1.03 5199 reflections 208 parameters 2 restraints H-atom parameters constrained Á max = 0.29 e Å À3 Á min = À0.29 e Å À3
Data collection: APEX2 (Bruker, 2004) ; cell refinement: SAINT (Bruker, 2004) ; data reduction: SAINT; program(s) used to solve structure: SIR92 (Altomare et al., 1993) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 1997); molecular graphics: ORTEP-3 (Farrugia, 1997); software used to prepare material for publication: PLATON (Spek, 2003) .
(3aRS,9bSR)-3-(4-Chlorophenyl)-1- methyl-1,2,3,3a,4,9b-hexahydrochromeno[4,3-b] 
Comment
Chromenopyrrole compounds are used in the treatment of impulsive disorders (Caine, 1993) , aggressiveness (Tidey, 1992) , parkinson's disease (Carlson, 1993) , psychoses, memory disorders (Sokoloff et al., 1990) , anxiety and depression (Wilner, 1985) . Pyrrole derivatives have good invitro against mycobacteria and candidae (Biava et al., 2005) . These derivatives also possess anti-inflammatory (Fernandes et al., 2004) and antiviral (Borthwick et al., 2000) activities. It has also been shown that N-substituted pyrrole derivatives inhibit human immuno deficiency virus type-I (HIV-I) (Jiang et al., 2004) . In view of its medicinal importance, the crystal structure determination of the title compound, (I), was carried out.
In the molecule of (I), (Fig. 1 ) the bond lengths and angles are within normal ranges (Allen et al., 1987) . The sum of bond angles around atom N1 [330.9 (4)°] indicates sp 3 hybridization. Rings A (C6-C11) and D (C13-C18) are, of course, planar and they are oriented at a dihedral angle of 46.7 (5)°. The heterocyclic ring B (O1/C4-C6/C11/C12) adopts a half-chair conformation with asymmetry parameters of ΔC 2 (C4) = 0.028 (1) (Nardelli, 1995) and puckering parameters of q 2 = 0.778 (3) Å, q 3 = 0.054 (2) Å and φ = − 26.5 (2)° (Cremer & Pople, 1975) . Atom C5 displaced by −0.645 (2) Å from the plane of the other five ring atoms. The pyrrolidine ring C (N1/C2-C4/C12) has an envelope conformation with asymmetry parameters of ΔC s (N1) = 0.030 (1) (Nardelli, 1995) and puckering parameters of q 2 = 0.470 (1) Å and φ =175.3 (2)° (Cremer & Pople, 1975) . Atom N1 displaced by −0.691 (2) Å from the plane of the other four ring atoms.
In the crystal structure, no significant intermolecular π-π interactions are observed between two chlorophenyl rings as their centroids are seperated by 4.1049 (9) Å. Weak intermolecular C-Cl···π interactions (Spek, 2003) , with C16···Cg4 = 3.680 (2) Å and Cl1···Cg4 = 3.858 (8) Å [Cg4 denotes centroid of ring D] and van der Waals forces stabilize the crystal structure ( Fig. 2) .
Experimental
For the preparation of the title compound, a solution of (Z)-2-((2-formyl-phenoxy)methyl)-3-(4-chlorophenyl)acrylonitrile (1 mmol) and sarcosine (1 mmol) in anhydrous methanol (10 ml) was refluxed. Completion of the reaction was evidenced by thin layer chromatography analysis. The solvent was removed in vacuum. The crude product was subjected to column chromatography on silica gel (100-200 mesh) using petroleum ether-ethylacetate (7:3) as the eluent. Compound was recrystallized from methanol.
Refinement
H atoms were positioned geometrically, with C-H = 0.93, 0.98, 0.97 and 0.96 Å for aromatic, methine, methylene and methyl H, respectively, and constrained to ride on their parent atoms, with U iso (H) = xU eq (C), where x = 1.5 for methyl H, and x = 1.2 for all other H atoms. Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > 2sigma(F 2 ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 )
x y z U iso */U eq Cl1 0.81942 (5) −0.45073 (7) 0.00516 (2) 0.06969 (17) (7) 0.0015 (7) 0.0177 (6) 0.0032 (6) C16 0.0371 (7) 0.0453 (7) 0.0517 (7) −0.0033 (6) 0.0100 (6) −0.0168 (6) C17 0.0453 (8) 0.0535 (9) 0.0573 (9) 0.0148 (7) 0.0016 (6) 0.0003 (7) supplementary materials sup-5 C18 0.0507 (8) 0.0507 (8) 0.0388 (6) 0.0079 (6) 0.0043 (6) 0.0037 (6) C19 0.0346 (6) 0.0396 (7) 0.0467 (7) 0.0047 (5) 0.0031 (5) 0.0015 (5) C20 0.0334 (7) 0.0812 (12) 0.0671 (10) 0.0026 (7) −0.0031 (7) −0.0231 (9) Geometric parameters (Å, °) 
